Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic drug interactions with topical glaucoma medications.

S L Gerber1, L B Cantor, D C Brater

  • 1Department of Ophthalmology, Indiana University School of Medicine, Indianapolis.

Survey of Ophthalmology
|November 1, 1990
PubMed
Summary

Topical ophthalmic glaucoma medications can reach the bloodstream, causing systemic side effects and interacting with other drugs. Evidence for these non-ocular drug interactions is often limited, especially in elderly patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining hypercalciuria in nephrolithiasis.

Kidney international·2011
Same author

Measurement of superficial optic nerve head capillary blood velocities by scanning laser fluorescein angiography.

Journal of glaucoma·2009
Same author

Acute Effect of Topical (beta-Adrenergic Antagonists on Normal Perimacular Hemodynamics.

Journal of glaucoma·2009
Same author

Effect of topical flurbiprofen on trabeculectomy.

Journal of glaucoma·2009
Same author

Drug dosing in patients with impaired renal function.

Clinical pharmacology and therapeutics·2009
Same author

Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills.

Clinical pharmacology and therapeutics·2009

Area of Science:

  • Pharmacology
  • Ophthalmology
  • Geriatrics

Background:

  • Topical ophthalmic medications can achieve significant systemic absorption.
  • Systemic absorption of ophthalmic drugs can lead to adverse effects and drug interactions.
  • Elderly patients often take multiple medications, increasing the risk of interactions.

Purpose of the Study:

  • To review and summarize existing information on non-ocular interactions of topical ophthalmic glaucoma medications.
  • To highlight the potential for drug interactions in patients using topical glaucoma treatments.

Main Methods:

  • Literature review of documented interactions between topical glaucoma drugs and systemically administered medications.
  • Analysis of warnings in drug information directories like the Physician's Desk Reference and United States Pharmacopeia Drug Information.

Related Experiment Videos

Main Results:

  • Topical ophthalmic drugs can reach serum concentrations sufficient to cause systemic effects.
  • Potential for interactions exists between topical glaucoma agents and orally/intravenously administered drugs.
  • Anecdotal reports and limited clinical evidence often support these interaction warnings.

Conclusions:

  • Topical ophthalmic glaucoma medications have the potential for systemic absorption and subsequent drug interactions.
  • Further research and robust clinical evidence are needed to fully understand these non-ocular interactions.
  • Clinicians should be aware of potential interactions, particularly in poly-medicated elderly patients.